MeSH tree: E05.242.384
Immunotherapy has become a standard of care in treating high-risk, early-stage breast cancers, yet it has had limited success in shrinking tumors. New biomarkers that can improve outcomes for patients are urgently needed. ...
May 3, 2026
0
23
Cancer claims more than 10 million lives every year globally. Research shows that detecting cancer early can greatly improve a patient's chance of survival. And yet we lack reliable, affordable tools for early detection.
May 2, 2026
0
7
Scientists from Johns Hopkins Medicine report new evidence that clusters of brain tissue derived from the cells of patients with Alzheimer's disease may be used to evaluate how certain patients with the neurodegenerative ...
Apr 20, 2026
0
7
Bladder cancer arises from the lining of the bladder, the organ that stores urine, and is one of the most common cancers in the United States. Most patients are diagnosed at an early stage called non-muscle invasive bladder ...
Apr 8, 2026
0
9
Dr. Jacquelyn Means knew that being pregnant in her late 30s would be challenging.
Mar 30, 2026
0
3
Home testing kits that screen for cervical cancer risk could be a game-changer for reducing health inequalities for physically disabled women, according to a new study revealing that over 50% would prefer a self-test over ...
Mar 26, 2026
0
3
In a study published in Nature Medicine, researchers from the University of Oxford and the Muhimbili University of Health and Allied Sciences (MUHAS) in Dar es Salaam, Tanzania have shown that a minimally invasive liquid ...
Mar 19, 2026
0
13
An innovative platform developed by PKU researchers called "cf-EpiTracing" has proved capable of detecting and tracing diseases from as little as 50 μl of human plasma, or roughly a drop of blood. The research, published ...
Mar 16, 2026
0
14
Heterotopic ossification (HO) is a common post-surgery condition where bone abnormally forms within soft tissues. A new study out of Mass General Brigham assesses the viability of a simple blood test to detect HO long before ...
Mar 3, 2026
0
8
Liquid biopsies, which test body fluids that contain cancerous material, including circulating tumor DNA (ctDNA), are a noninvasive way to learn about a cancer's biology. However, technological limitations with the small ...
Feb 17, 2026
0
13
